StockData
RMHIOTCPharmaceutical PreparationsFiscal year ends September 30

Retrieve Medical Holdings, Inc.

Financials through Q1 FY2023, quarter ended Dec 31, 2022Last filing: 10-Q on Feb 9, 2023
$0.85+0.01 (+1.78%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

About Retrieve Medical

Pharmaceutical Preparations, SIC 2834

Peak Pharmaceuticals, Inc. operates as a shell company seeking to acquire or merge with an active operating business to create a viable commercial enterprise. The entity previously focused on developing, manufacturing, and marketing medicinal and health products containing hemp-derived phytocannabinoids, including ingestible pet wellness products under the Canna-Pet brand and proposed over-the-counter treatments for inflammatory diseases. Following regulatory actions and guidance concerning hemp-based pet and health formulations, the company terminated its licensing agreements, sold related operational assets, and discontinued all cannabinoid product development efforts.

The entity currently maintains no active product lines, customers, or commercial business operations. It employs zero personnel, with corporate activities managed exclusively by its sole executive officer and director. Peak Pharmaceuticals maintains its principal executive offices in Scottsdale, Arizona. All historical business operations were conducted through its wholly owned operating subsidiary, Peak BioPharma Corp.

Summary of the business section of Retrieve Medical's latest annual report, written by StockData.

Company profile

Company

Legal name
Retrieve Medical Holdings, Inc.
Founded
2007
Headquarters
Bedminster, NJ
Address
376 Main Street, Suite 100 07921
Phone
(908) 800-2880
Employees
1, Sep 30, 2017
Industry
Pharmaceutical Preparations
Incorporated in
Nevada
Fiscal year ends
September 30
Auditor
Friedman LLP, Marlton, New Jersey

Stock & identifiers

Ticker
RMHI
Exchange
OTC
Shares outstanding
78M, Feb 8, 2023
Public float
$5.08M, Mar 31, 2022
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
3-for-2, May 14, 2014; 3-for-2, Apr 1, 2014; 50-for-1, Dec 26, 2012
SEC CIK
1452804
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Retrieve Medical's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“As of the date of this report we have 1 employee, Neil Reithinger, our principal executive officer.”

Corporate history

Events identified from SEC filings

DateEventDetails
Mar 21, 2023DeregistrationTermination of SEC registration (Form 15)
Mar 21, 2023Name changeName changed from PEAK PHARMACEUTICALS, INC. to Retrieve Medical Holdings, Inc.
Jan 20, 2023Auditor changeChange in certifying accountant (8-K Item 4.01)
Jul 13, 2020DeregistrationTermination of SEC registration (Form 15)
Dec 31, 2018Late filingNotification of late filing
Feb 15, 2018Late filingNotification of late filing
Dec 28, 2017Late filingNotification of late filing
Jul 18, 2016Auditor changeChange in certifying accountant (8-K Item 4.01)
May 16, 2016Late filingNotification of late filing
Feb 12, 2016Late filingNotification of late filing
Dec 28, 2015Late filingNotification of late filing
Oct 13, 2015Auditor changeChange in certifying accountant (8-K Item 4.01)
Dec 29, 2014Late filingNotification of late filing
Dec 29, 2014Name changeName changed from CANNABIS THERAPY CORP. to PEAK PHARMACEUTICALS, INC.
Mar 20, 2014Name changeName changed from FRAC WATER SYSTEMS, INC. to CANNABIS THERAPY CORP.
Feb 14, 2014Late filingNotification of late filing
Jul 29, 2013Name changeName changed from SURF A MOVIE SOLUTIONS INC to FRAC WATER SYSTEMS, INC.